Refine by
Gene Therapy Articles & Analysis
238 news found
In many research applications, such as gene expression studies, vaccine development, and gene therapy, transfection—the process of introducing nucleic acids into cells—is an essential step. ...
About Protheragen Protheragen specializes in providing a range of preclinical research services for rare disease research, addressing many of the challenges encountered in drug discovery and development. Its end-to-end rare disease therapy development solutions cover a full package of therapeutic development services, which include small molecule, cell therapy, ...
As of the latest research, several experimental gene therapies for glaucoma are in various stages of development, from preclinical studies to early-phase clinical trials. ...
This strategic move is aimed at addressing the rising global demand for Lipid Nanoparticles (LNPs), which are vital for nucleic acid drug delivery, especially in mRNA-based therapies and vaccines. Lipid Nanoparticles have become a groundbreaking delivery mechanism within the biopharmaceutical sector. ...
Advanced Instruments, a leading provider of analytical instruments and services for clinical and biopharmaceutical laboratories, is proud to announce the expansion of its Artel portfolio’s direct presence in Austria, France, Germany, and Switzerland. This strategic move underscores Advanced Instruments’ commitment to providing unparalleled access to their liquid volume verification ...
Remarkably, BOC Sciences can provide tailored exosomes filled with siRNA, which has led to several successful cases in the development of gene therapies and innovative drug delivery systems. Initially, BOC Sciences creates and synthesizes siRNA that targets specific genes, and then incorporates them into the exosomes. ...
Boston: Microneedle technology, driven by high demand in dermatologic procedures and its versatile applications in drug delivery, vaccine administration, and disease diagnostics, faces challenges in its complex manufacturing process. Ongoing research and numerous products in development make this market dynamic for newcomers entering the field. “According to the latest BCC Research study, ...
In the biopharma space, its Solentim portfolio of best-in-class imaging and single-cell deposition technologies enable the clonal isolation, outgrowth, and characterization of the highest value cells for monoclonal antibody upstream development and cell and gene therapy. Its OsmoTECH® line of micro-osmometers are built specifically to support workflows ...
As several gene therapy approvals for rare disease treatment gain steam in 2023, a comprehensive set of gene therapy development solutions is released to pave richer avenues for rare disease research. ...
“Our innovative drug delivery solutions are ideal for a wide range of pharmaceutical and biotech applications, such as gene therapy, immunotherapy, hormonal therapy, anti-infectives, and vaccines,” said the Marketing Chief of CD Formulation. ...
Compared with conventional formulations, microspheres enable long-term and stable drug release in the body, making them a perfect choice for immunization, gene therapy and tumor chemotherapy. “With the increasing demand for targeted drug delivery and minimally invasive procedures, there is a growing need for high-quality polymer microspheres and raw ...
Unlike DNA and viral vectors, mRNA will not be inserted into the host genomes that modify genetic information, and proteins encoded by mRNA fragments will only be expressed instantaneously and then degraded rapidly, minimizing the risk of gene integration and being highly safe. Moreover, compared with proteins and viruses, which encounter rapid degradation, mRNA fragments can ...
Ultimately, personalized medicine could be key in helping us tackle some of the world’s most pressing medical issues. Advances in gene therapy Gene therapy has made huge strides over the past decade due to advancements in technology and knowledge of human biology. This treatment is used to modify or replace an ...
"To realize the modality's potential, we have therefore focused our efforts over the past two years on scalable productization – developing an allogeneic off-the-shelf product – and research on new therapeutic applications of mitochondria – such as in gene therapy delivery and aging related degeneration." With this additional funding, cellvie ...
In recent years, applications of viral vectors have found an encouraging new beginning in gene therapy and in vaccine development. What can viral vectors be used for? Substantial improvements in viral vector manufacturing, delivery, and safety have placed viral vector-based therapy at the forefront of modern medicine. Viral ...
ByNuvonis
Caroline Man Xu, Co-founder and CEO of ViGeneron said:” Recombinant AAV vectors are an established platform for effective gene therapies today. However, their limited packaging capacity and transduction efficacy are a major challenge for the development of novel gene therapies. ...
ViGeneron GmbH, a gene therapy company, announced the closing of its series A financing round led by WuXi AppTec and Sequoia Capital China. The proceeds will enable ViGeneron to accelerate its proprietary viral vector-based gene therapy platforms and drive product development in its two lead ophthalmic gene ...
“In addition, positive study outcomes from our cell & gene therapy platforms offer a potential upside that is hard to quantify exactly today but can reach multi-billion Euro ...
ByBayer AG
“Through this collaboration, we have an opportunity to advance AskBio’s gene editing and nonviral delivery efforts, which support and align with our commitment to serve as an industry-leading engine of gene therapy ...
ByBayer AG
Gene expression and therapy involves the introduction of foreign nucleic acids into target cells to modify or compensate for gene defects, thereby treating diseases such as cancer, diabetes, autoimmune diseases, and infectious diseases. ...